AI assistant
Sending…
AtriCure, Inc. — Director's Dealing 2015
May 8, 2015
31802_dirs_2015-05-08_fd10f692-5909-4755-9fc2-085296d2e8ec.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2015-05-06
Reporting Person: ROBARDS KAREN P (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-05-06 | Common Stock | M | 5000 | $12.00 | Acquired | 290978 | Direct |
| 2015-05-06 | Common Stock | S | 2650 | $22.18 | Disposed | 288328 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-05-06 | Stock Option (right to buy) | $12.00 | M | 5000 | Disposed | 2015-08-05 | Common Stock (5000) | Direct |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $22.00 to $22.50 per share. The price reported above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2: These options were granted on August 5, 2005 and are exercisable cumulatively at a rate of 25% per annum beginning one year from date of grant.
More from AtriCure, Inc.
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 19
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 6
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3